ZNTL - Zentalis Pharmaceuticals Inc

Healthcare - Sector

ZNTL is currently covered by 3 analysts with average potential upside of $20.99 (42.43%) backed by 1 price targets and 13 ratings. Analyst's average stock valuation to be materialised ratio is 33.33% with an average time for price targets to be met of 78 days.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 14-Nov-2022.

Highest price target for ZNTL is 79, Lowest price target is 22, average price target is 50.5.

Best performing analysts who are covering ZNTL - Zentalis Pharmaceuticals Inc:

Andrew Berens Bradley Canino Matthew Biegler Eliana Merle Robert Driscoll

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

32

$11.35 (54.96%)

89

15 days ago

1/3 (33.33%)

$13.04 (31.52%)

222

Buy

74

$53.35 (258.35%)

94

7 months 18 days ago

1/3 (33.33%)

$31.67 (74.16%)

33

Buy

97

7 months 18 days ago

2/4 (50%)

$15.61 (28.17%)

84

Buy

90

$68.34 (315.51%)

1 years 1 months 28 days ago

0/1 (0%)

$22.87 (34.07%)

Buy

91

$70.35 (340.68%)

44

1 years 6 months 8 days ago

1/2 (50%)

$21.78 (44.24%)

51

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login